Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (441-450 of 670) with videos related to

Pageof 67
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging TherapiesMark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
JAAD International|March 28, 2024
Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Angel Cronin, Eric A Jones, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 2, 2019
Conceptual Model to Illustrate the Symptom Experience and Humanistic Burden Associated With Atopic Dermatitis in Adults and AdolescentsLaura Grant, Lotte Seiding Larsen, Claire Trennery, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2025
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studiesSonja Ständer, Sarina B Elmariah, Shawn G Kwatra, et al.
Journal of Drugs in Dermatology : JDD|February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in PracticeMark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
The Journal of Investigative Dermatology|October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring SystemMaria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
Journal of the American Academy of Dermatology|August 14, 2020
Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control studyJonas A Adalsteinsson, Sonal Muzumdar, Reid Waldman, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical reviewJonathan I Silverberg, Mark Boguniewicz, Francisco J Quintana, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2020
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation studyJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
The Journal of Investigative Dermatology|June 28, 2025
The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United StatesChristopher G Bunick, April W Armstrong, Ayman Grada, et al.
Pageof 67

Showing results (441-450 of 670) with videos related to

Sort By:
Pageof 67
The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging TherapiesMark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
JAAD International|March 28, 2024
Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Angel Cronin, Eric A Jones, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 2, 2019
Conceptual Model to Illustrate the Symptom Experience and Humanistic Burden Associated With Atopic Dermatitis in Adults and AdolescentsLaura Grant, Lotte Seiding Larsen, Claire Trennery, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2025
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studiesSonja Ständer, Sarina B Elmariah, Shawn G Kwatra, et al.
Journal of Drugs in Dermatology : JDD|February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in PracticeMark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
The Journal of Investigative Dermatology|October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring SystemMaria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
Journal of the American Academy of Dermatology|August 14, 2020
Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control studyJonas A Adalsteinsson, Sonal Muzumdar, Reid Waldman, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical reviewJonathan I Silverberg, Mark Boguniewicz, Francisco J Quintana, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2020
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation studyJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
The Journal of Investigative Dermatology|June 28, 2025
The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United StatesChristopher G Bunick, April W Armstrong, Ayman Grada, et al.
Pageof 67